Join Us for a Summit Exploring

3D Printed Pharmaceuticals

November 8, 2018 | Westminster Hotel | Livingston, NJ

It is important to stay ahead of the technology curve to prepare “for a significant wave of new technologies that are nearly certain to transform medical practice.”

– FDA Commissioner, Scott Gottlieb

Featuring our keynote speaker

Janet Woodcock, M.D.
Director of the FDA's Center for Drug Evaluation and Research

CMPI believes now is the right time to pursue an in-depth conversation about what has been learned since the FDA’s groundbreaking approval and what changes we should expect to see in the immediate future.

Janet Woodcock

The Center for Medicine in the Public Interest would like to invite you to our first Summit on 3D Printing: Exploring the Impact on Pharmaceuticals and Patient Health.

Less than three years ago, the FDA approved the first 3D printed pharmaceutical. At the time, it was heralded as the dawn of a technological transformation that would produce wide-ranging positive changes across all segments of the pharmaceutical industry.

This summit brings together the leaders in 21st-century medical manufacturing from private industry, academic and government agencies with a wide range products, patient organizations, and groups dedicated to eradicating disease across the globe. RSVP Now to Save Your Spot

Please Join Us On

Thursday, November 8, 2018

  • 8:00 a.m. - Breakfast
  • 8:30 a.m. - Opening Remarks
  • 3:00 p.m. – Closing Remarks

Westminster Hotel
550 W. Mt. Pleasant Avenue
Livingston, NJ 07078


Featuring Speakers From Across the Industry

Tim Tracy
Tim Tracy, CEO Aprecia Pharmaceuticals which developed the world’s first FDA approved 3-D printed medicine
Tim Rothwell
Tim Rothwell, Chairman and CEO Emeritus, Sanofi-Aventis and Chairman of Emisphere
John Hornick
John Hornick, an expert on the impact of 3-D printing on social, legal and commercial institutions and the noted author of “How 3-D Printing Will Rock the World

Join Us on November 8, 2018 to Include Your Voice in this Important Conversation

CMPI sees this summit as a gathering of the most significant individuals and organizations that will determine the future of 3-D printing. This is an invitation only event that will be limited to 75 people to facilitate discussion and encourage interaction among the leaders in 3-D pharmaceutical printing.

We encourage you to RSVP Now and join us at this most important event.